Georgia to launch clinical trials on four drugs to treat COVID -19

Georgia is involving in a study by the World Health Organization (WHO) and, within the frameworks of this cooperation, clinical trials will be launched on four drugs to determine their potential for treating COVID-19.

As Tengiz Tsertsvadze, Director of the Tbilisi Infectious Diseases Hospital, said in his interview with InterPressNews, the study aims to find the most effective medicine for the treatment of the coronavirus.

According to him, the following drugs will be tested in the patients infected with the coronavirus : Remedisvir, Plaquenil, Lopinavir / Ritonavir, containing Interferon Alpha, and Lopinavir / Ritonavir, containing Interferon Beta.

Tengiz Tsertsvadze said 7 clinics will be involved in the trials: Infectious Diseases Hospital, Bochorishvili Clinic, First University Clinic, Republican Hospital, Batumi Hospital Medalfa, Gori Military Hospital and Sachkhere Hospital.

According to the Director of the Tbilisi Infectious Diseases Hospital, involvement of patients in the trials will be voluntary.